This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bentur, Y. Articles by Taitelman, U. Search for Related Content PubMed PubMed Citation Articles by Bentur, Y. Articles by Taitelman, U. Social Bookmarking                         What's this?

Postmortem digoxin-like immunoreactive substances (DLIS) in patients not treated with digoxin

Israel Poison Information Center, Rambam Medical Center, PO Box 9602, Haifa 31096, Israel

Alla Tsipiniuk

Israel Poison Information Center, Rambam Medical Center, PO Box 9602, Haifa 31096, Israel

Uri Taitelman

General Intensive Care Unit, Rambam Medical Center, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

1 Endogenous digoxin-like immunoreactive substances (DLIS) cross-react in immunoassays of digoxin. The postmortem rise in digoxin levels in patients treated with the drug may be due to its redistribution. It is unclear what is the contribution of DLIS to this increase and whether DLIS are present postmortem in patients not treated with digoxin.

2 The objectives of this study were to determine whether DLIS are present after death in patients not treated with digoxin, whether a postmortem increase in DLIS is detectable and whether sampling site can affect DLIS concentrations.

3 DLIS (measured as digoxin, TDx Abott) were determined in blood samples drawn antemortem from ICU patients; postmortem samples from femoral artery and cardiac chambers were taken at least 12 h after the death of these same patients.

4 DLIS concentrations 0.2 ng/ml were measured in 44 and 40% of patients antemortem and postmortem (femoral), respectively. No difference was found in DLIS levels between antemortem and postmortem femoral and cardiac samples. Age, ICU stay and postmortem sampling time did not affect the postmortem increase in DLIS. None of the levels was in the toxic range.

5 DLIS may be present after death and their concentration does not increase postmortem. The interpretation of postmortem digoxin concentrations that fall in the therapeutic range should be done cautiously; such measurable levels do not necessarily indicate misuse or malicious intent even in patients who had not been treated with the drug.

Key Words: digoxin • digoxin-like immunoreactive substances • postmortem

Human & Experimental Toxicology, Vol. 18, No. 2, 67-70 (1999)
DOI: 10.1177/096032719901800201


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?